FDA cGMP Requirements for PET Drugs

被引：0

|

作者：

Norenberg, Jeffrey P.

Schwarz, Sally

VanBrocklin, Henry

机构：

来源：

JOURNAL OF NUCLEAR MEDICINE | 2011年 / 52卷 / 05期

关键词：

D O I：

暂无

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

引用

收藏

页码：16N / 16N

页数：1

相关论文

共 50 条

[41] Glaxo drugs seized by FDA
Mccoy, M
CHEMICAL & ENGINEERING NEWS, 2005, 83 (11) : 11 - 11
[42] Meeting FDA process validation requirements
SIMS Deltec, St. Paul, United States
Medical Device and Diagnostic Industry, 1996, 18 (07):
[43] CURRENT STATUS OF FDA TOXICITY REQUIREMENTS
FANCHER, OE
CALANDRA, JC
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1968, 153 (A1) : 258 - &
[44] FDA approves landmark drugs
不详
NATURE REVIEWS DRUG DISCOVERY, 2012, 11 (03) : 177 - 177
[45] FDA warns on imported drugs
不详
CHEMICAL & ENGINEERING NEWS, 2002, 80 (50) : 27 - 27
[46] NEW DRUGS AND FDA PUBLICITY
PINES, WL
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1983, 17 (09): : 671 - 672
[47] NEW DRUGS - AMA AND FDA
APPEL, JZ
ANNALS OF ALLERGY, 1966, 24 (07): : 333 - &
[48] FDA seizes GSK drugs
不详
TCE, 2005, (766): : 4 - 4
[49] FDA acts on unapproved drugs
不详
CHEMISTRY WORLD, 2007, 4 (04): : 16 - 16
[50] FDA weighs in on nitrosamines in drugs
Erickson, Britt
CHEMICAL & ENGINEERING NEWS, 2020, 98 (34) : 15 - 15

← 1 2 3 4 5 →